Dark Forest Capital Management’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,165
Closed -$39.3K 1134
2025
Q2
$39.3K Buy
+10,165
New +$55K ﹤0.01% 1139
2024
Q2
Sell
-16,105
Closed -$164K 645
2024
Q1
$164K Buy
+16,105
New +$164K 0.03% 642
2023
Q4
Sell
-230,353
Closed -$599K 467
2023
Q3
$599K Buy
230,353
+27,210
+13% +$78.1K 0.05% 629
2023
Q2
$717K Buy
203,143
+159,208
+362% +$715K 0.07% 456
2023
Q1
$185K Buy
+43,935
New +$522K 0.04% 421
2022
Q4
Sell
-1,696
Closed -$22K 1125
2022
Q3
$22K Buy
+1,696
New +$25K ﹤0.01% 614

Other funds holding ALT

Dark Forest Capital Management's ALT Position: Q3 2025 in Review

Dark Forest Capital Management sold out of Altimmune (ALT) in Q3 2025, closing a stake of 10,165 shares — an estimated $39.3K sold.

Dark Forest Capital Management first reported a position in ALT in Q3 2022 and held it in 6 quarters. The position peaked at $717K in Q2 2023. 158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

  • Dark Forest Capital Management reported no remaining Altimmune position as of Q3 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 10,165 Altimmune shares in Q3 2025, an estimated $39.3K.
  • Dark Forest Capital Management first reported a position in Altimmune in Q3 2022 and held it in 6 quarters.
  • Dark Forest Capital Management's Altimmune position peaked at $717K in Q2 2023.
  • 158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on Dark Forest Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.